Limb Amputation clinical trials

Explore recruiting limb amputation clinical trials.

Recruiting limb amputation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Limb Amputation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its influence on endothelial function in patients undergoing endovascular treatment due to peripheral arterial disease.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Augmenting ischemia-induced vasculo- and angiogenesis after endovascular reperfusion with host-extracted, percutaneously introduced, leucocyte- and platelet-rich fibrin in patients with critical limb ischemia

Poland

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Healing Diabetic Foot Ulcers with Semaglutide

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Belgium, Czechia, Poland, France, Finland, Portugal +16 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hydralazine-ISDN in Patients With Chronic Heart Failure - Hydralazine Heart Failure Trial (H-HeFT) Metformin in Patients with Chronic Heart Failure and Diabetes or Insulin Resistance - Metformin Heart Failure Trial (Met-HeFT) A randomized, 2 x 2 factorial designed, double-blind, placebo controlled study (DANHEART).

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to evaluate Efficacy and Safety of Empagliflozin in the prevention of Cardiotoxicity in Cancer patients undergoing Chemotherapy based on Anthracyclines (EMPACT study)

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Limb Amputation trials by city

Limb Amputation in Toronto Limb Amputation in Vancouver Limb Amputation in Montreal Limb Amputation in Calgary Limb Amputation in Edmonton Limb Amputation in Ottawa Limb Amputation in Winnipeg Limb Amputation in Quebec City Limb Amputation in Hamilton Limb Amputation in Kitchener Limb Amputation in London Limb Amputation in Halifax Limb Amputation in New York Limb Amputation in Los Angeles Limb Amputation in Chicago Limb Amputation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease